- News & Analysis
Deals
First-time equity deals in UK spinouts fall 22% — report
The number of deals in UK spinouts at the earliest stage of equity investing has been falling over the past few years, highlighting a potential bottleneck in early-stage funding.
Sep 16, 2024Cleerly captures investors’ hearts in $192m series C
Launched just a year ago to build on work at Weill Cornell Medicine and New York-Presbyterian Hospital, Cleerly has now closed an oversubscribed series C round.
Jul 25, 2022CardiaTec captures $1.7m
Cambridge Enterprise has put cash into CardiaTec Biosciences in a pre-seed round that marks the inaugural deal for Laidlaw Scholars Ventures.
Jul 6, 2022OQC heads to Japan after $46m series A
Oxford Quantum Circuits' series A round is already among the largest for a European quantum company and could still go higher.
Jul 5, 2022ReCode registers $120m series B extension
UT Southwestern Medical Center spinout ReCode Therapeutics has now raised a total of $200m in its series B round from investors including Osage University Partners.
Jun 30, 2022Zap Energy zips to $160m series C
University of Washington spinout Zap Energy is working on building a cheap, scalable fusion reactor generating low cost and carbon free energy.
Jun 28, 2022MicroTransponder manifests $53m series E
Osage University Partners has added MicroTransponder to a small but mightly portfolio of medical device companies.
Jun 23, 2022Elypta elicits $21m series A
Chalmers spinout Elypta is working on a metabolism-based liquid biopsy for early cancer detection that it hopes will catch any type of the disease.
Jun 21, 2022Categories
EventsGCV Institute: CVC Investment ProgramsDec 3 -
Dec 4, 2024
OnlineEventsGCV Connect: Korea 2024Dec 10 -
Dec 12, 2024
Seoul (South Korea)EventsGCV Institute: CVC Investment ProgramsJan 28 -
Jan 29, 2025
OnlineEventsGCV Institute: CVC Investment ProgramsMar 17 -
Mar 18, 2025
Palo Alto, CA (USA)EventsGCVI Summit 2025Mar 18 -
Mar 20, 2025
Monterey, CA (USA)EventsGCV Institute: Landing the Value of Corporate VenturingMay 1 -
May 6, 2025
OnlineEventsGCV Symposium 2025Jun 17 -
Jun 19, 2025
London (UK)Top NewsNews Continued
Deals: June 1, 2022
Orphan CNS therapy developer Minoryx Therapeutics closed a $54.8m series C and MIT's The Engine co-led a $10.5m seed round for Foundation Alloy.
Jun 1, 2022
Exits: May 31, 2022
Evotec has bought University of Modena and Reggio Emilia spinout Rigenerand for $24.7m.
May 31, 2022
Deals: May 31, 2022
ZGT has raised $48m from Tsinghua Holdings Capital, CAS Star and others, while University of Cambridge spinout Colorifix has pocketed $22.7m.
May 31, 2022
Deals: May 27, 2022
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
May 27, 2022
Exits: May 26, 2022
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
May 26, 2022
Deals: May 26, 2022
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
May 26, 2022Editor's Picks
OQC heads to Japan after $46m series A
Oxford Quantum Circuits' series A round is already among the largest for a European quantum company and could still go higher.
Jul 5, 2022
CFS sparks $1.8bn series B
MIT spinout Commonwealth Fusion Systems has raised the largest funding round yet for a nuclear fusion developer with investors including The Engine.
Dec 1, 2021
Aerovate accesses public markets
Less than a year after raising $72.6m in its series A round, Aerovate Therapeutics has gone public following an IPO worth more than $121m.
Jul 1, 2021Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Mar 18, 2019
About us
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
Navigation
